Ginkgo biloba per Cerebrovascular Health
B Evidenze Almeno un trial randomizzato lo supporta, con risultati per lo più coerenti.Research suggests Ginkgo may help enhance cerebral blood flow through vasodilation. More consistent benefits are observed for vascular-related cognitive symptoms than for general cognitive decline.
In sintesi
Research suggests Ginkgo may help enhance cerebral blood flow through vasodilation. More consistent benefits are observed for vascular-related cognitive symptoms than for general cognitive decline.
Key Study Findings
Popolazione: elderly patients with mild cognitive impairment or chronic brain diseases
Popolazione: Male Sprague-Dawley rats with DVT model
Popolazione: HT22 mouse hippocampal neurons under OGD/R
Popolazione: APP/PS1 transgenic Alzheimer's disease mouse model
Popolazione: Ischemic stroke patients (narrative review)
Popolazione: BCAS cerebral small vessel disease mouse model
Key Statistics
12
Studi
2000
Partecipanti
Positive
Grado
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Dosaggi di uso comune
- general:
- 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones
Limite massimo: 600 mg/day (doses above show no additional benefit)
Dosaggi studiati nella ricerca
| Dosaggio | Durata | Effetto | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | 10 weeks | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | 22347 |
| None | -- | Positive | -- |
Momento migliore per l'assunzione: With meals; may require 4-6 weeks for full effects
Safety & Side Effects
Effetti collaterali segnalati
- ⚠ Headache
- ⚠ Gastrointestinal upset
- ⚠ Dizziness
- ⚠ Allergic skin reactions (rare)
- ⚠ Increased bleeding risk
Interazioni note
- ● Anticoagulants and antiplatelet drugs (increased bleeding risk)
- ● Anticonvulsants (may reduce seizure threshold)
- ● SSRIs (serotonin syndrome risk, rare)
- ● CYP3A4 substrates (may affect drug metabolism)
Livello di assunzione massimo tollerabile: 600 mg/day (doses above show no additional benefit)
Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.
Frequently Asked Questions
Does Ginkgo biloba help with Cerebrovascular Health?
How much Ginkgo biloba should I take for Cerebrovascular Health?
Are there side effects of Ginkgo biloba?
How strong is the evidence for Ginkgo biloba and Cerebrovascular Health?
Related Evidence
Altri ingredienti per Cerebrovascular Health
Ginkgo biloba per altre condizioni
References
- [1] F Abad-Santos et al.. Rev Neurol. [Treatment of mild cognitive impairment: value of citicoline]. PubMed
- [2] Jinfa Du et al.. Proc Natl Acad Sci U S A. 2025. Identification of a central regulator of ginkgolide biosynthesis in Ginkgo biloba that integrates jasmonate and light signaling. doi:10.1073/pnas.2408891122 PubMed
- [3] Ting Yu et al.. Phytomedicine. 2025. Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of Alzheimer's disease. doi:10.1016/j.phymed.2025.156646 PubMed
- [4] Xing-Yuan Li et al.. J Ethnopharmacol. 2025. Inhibition of mitochondrial oxidative stress and apoptosis in the protection of Ginkgo biloba extract 50 against cognitive impairment. doi:10.1016/j.jep.2025.120059 PubMed
- [5] Cuicui Cheng et al.. Phytomedicine. 2025. Yindan Xinnaotong Soft Capsule improves post-ischemic stroke recovery by regulating CREB/BDNF-mediated synaptic plasticity and CREB/VEGFA-mediated angiogenesis. doi:10.1016/j.phymed.2025.157155 PubMed
- [6] Federico Masserini et al.. Alzheimers Dement. 2025. Therapeutic strategies in vascular cognitive impairment: A systematic review and meta-analysis. doi:10.1002/alz.70840 PubMed
- [7] S Sowmiya et al.. Front Pharmacol. 2025. Traditional, complementary, and integrative medicine in the management of ischemic stroke: a narrative review. doi:10.3389/fphar.2025.1561688 PubMed
- [8] H Yang et al.. Niger J Clin Pract. 2025. Antithrombotic Effect of Ginkgo Biloba Extract: A Study Based on Network Pharmacological Analysis and In vivo Experiments. doi:10.4103/njcp.njcp_770_24 PubMed
- [9] Dexiu Wang et al.. Metab Brain Dis. 2025. Ginkgo biloba extract mediates HT22 cell proliferation and migration after oxygen-glucose deprivation/reoxygenation via regulating RhoA-ROCK2 signalling pathway. doi:10.1007/s11011-024-01502-9 PubMed
- [10] Nasser M Aldekhail et al.. Altern Ther Health Med. 2025. Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines. PubMed
- [11] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
- [12] Weile Ye et al.. Acta Pharm Sin B. 2024. [Not Available]. doi:10.1016/j.apsb.2023.09.014 PubMed
- [13] Liang-Yi Chen et al.. Physiol Rep. 2024. Anti-oxidative and anti-inflammatory effects of Ginkgo biloba extract (EGb761) on hindlimb skeletal muscle ischemia-reperfusion injury in rats. doi:10.14814/phy2.16050 PubMed
- [14] Qiuhong Zhu et al.. Pak J Pharm Sci. 2024. Clinical efficacy and mechanism of Ginkgo biloba extract in the treatment of elderly ischemic cerebrovascular disease. PubMed
- [15] Huan Han et al.. J Plant Physiol. 2023. Ginkgo biloba GbbZIP08 transcription factor is involved in the regulation of flavonoid biosynthesis. doi:10.1016/j.jplph.2023.154054 PubMed
- [16] Ting Yu et al.. Pharmaceutics. 2023. Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a Mouse Model of Alzheimer's Disease. doi:10.3390/pharmaceutics15122746 PubMed
- [17] Tingchun Wu et al.. BMJ Open. 2023. Efficacy and safety of Ginkgo biloba dropping pills in the treatment of coronary heart disease with stable angina pectoris and … doi:10.1136/bmjopen-2021-055263 PubMed
- [18] Taizen Nakase et al.. PLoS One. 2023. Efficacy of a mixture of Ginkgo biloba, sesame, and turmeric on cognitive function in healthy adults: Study protocol for a … doi:10.1371/journal.pone.0280549 PubMed
- [19] Yanxia Liu et al.. J Ethnopharmacol. 2022. Leaves, seeds and exocarp of Ginkgo biloba L. (Ginkgoaceae): A Comprehensive Review of Traditional Uses, phytochemistry, pharmacology, resource utilization and … doi:10.1016/j.jep.2022.115645 PubMed
- [20] Min Xu et al.. J Integr Neurosci. 2022. Traditional medicine in China for ischemic stroke: bioactive components, pharmacology, and mechanisms. doi:10.31083/j.jin2101026 PubMed
- [21] José María García-Alberca et al.. Clin Drug Investig. 2022. Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia. doi:10.1007/s40261-022-01136-8 PubMed
- [22] Fang Cao et al.. J Ethnopharmacol. 2022. Ginkgo biloba L. extract prevents steroid-induced necrosis of the femoral head by rescuing apoptosis and dysfunction in vascular endothelial cells … doi:10.1016/j.jep.2022.115476 PubMed
- [23] Li-Tao Wang et al.. Phytomedicine. 2022. Biflavonoids from Ginkgo biloba leaves as a novel anti-atherosclerotic candidate: Inhibition potency and mechanistic analysis. doi:10.1016/j.phymed.2022.154053 PubMed
- [24] Jie Zhang et al.. Gynecol Endocrinol. 2022. Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a … doi:10.1080/09513590.2022.2034147 PubMed
- [25] Jie Zhang et al.. Gynecol Endocrinol. 2022. Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a … doi:10.1080/09513590.2021.2011198 PubMed
- [26] Wen-Ming Yang et al.. Zhongguo Zhong Yao Za Zhi. 2022. [Expert consensus on clinical application of GBE50 Dispersible Tablets for ischemic cardiovascular and cerebrovascular diseases]. doi:10.19540/j.cnki.cjcmm.20210809.501 PubMed
- [27] Ju Wang et al.. Front Cell Neurosci. 2021. Traditional Chinese Medicine Monomers: Novel Strategy for Endogenous Neural Stem Cells Activation After Stroke. doi:10.3389/fncel.2021.628115 PubMed
- [28] Nagaendran Kandiah et al.. CNS Neurosci Ther. 2021. Strategies for the use of Ginkgo biloba extract, EGb 761® , in the treatment and management of mild cognitive impairment … doi:10.1111/cns.13536 PubMed
- [29] Shuang Zhao et al.. Evid Based Complement Alternat Med. 2021. The Clinical Efficacy of Ginkgo biloba Leaf Preparation on Ischemic Stroke: A Systematic Review and Meta-Analysis. doi:10.1155/2021/4265219 PubMed
- [30] Brittany R Block et al.. Sr Care Pharm. 2021. Online Promotion of "Brain Health" Supplements. doi:10.4140/TCP.n.2021.489 PubMed
- [31] Gang Gong et al.. Biomed Pharmacother. 2020. Isorhamnetin: A review of pharmacological effects. doi:10.1016/j.biopha.2020.110301 PubMed
- [32] Phui Zee Chong et al.. Am J Chin Med. 2020. Efficacy and Safety of Ginkgo biloba in Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. doi:10.1142/S0192415X20500263 PubMed
- [33] Dan Wu et al.. Zhongguo Zhong Yao Za Zhi. 2020. [Similarities and differences between Ginkgo biloba and Panax notoginseng in treatment of ischemic cerebrovascular disease]. doi:10.19540/j.cnki.cjcmm.20200313.402 PubMed
- [34] Nagaendran Kandiah et al.. CNS Neurosci Ther. 2019. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba … doi:10.1111/cns.13095 PubMed
- [35] Egemen Savaskan et al.. Int Psychogeriatr. 2018. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of … doi:10.1017/S1041610217001892 PubMed
- [36] Wei Zuo et al.. Aging Dis. 2017. Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Diseases. doi:10.14336/AD.2017.0615 PubMed
- [37] Yinfeng Yang et al.. ACS Chem Biol. 2017. Systematic Investigation of Ginkgo Biloba Leaves for Treating Cardio-cerebrovascular Diseases in an Animal Model. doi:10.1021/acschembio.6b00762 PubMed
- [38] Philippa A Jackson et al.. Nutrients. 2016. DHA Supplementation Alone or in Combination with Other Nutrients Does not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older … doi:10.3390/nu8020086 PubMed
- [39] Xinhua Zhou et al.. Evid Based Complement Alternat Med. 2016. Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine. doi:10.1155/2016/9627258 PubMed
- [40] Ying Deng et al.. Phytother Res. 2016. Effect of Ginkgo Biloba Extract on the Pharmacokinetics and Metabolism of Clopidogrel in Rats. doi:10.1002/ptr.5691 PubMed
- [41] Kevin M Nash et al.. Integr Med Insights. 2015. Current Perspectives on the Beneficial Role of Ginkgo biloba in Neurological and Cerebrovascular Disorders. doi:10.4137/IMI.S25054 PubMed
- [42] Pedro Montes et al.. CNS Neurol Disord Drug Targets. 2015. Ginkgo biloba Extract 761: A Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders. doi:10.2174/1871527314666150202151440 PubMed
- [43] Wen Zheng et al.. Proteomics. 2015. Improved metabolites of pharmaceutical ingredient grade Ginkgo biloba and the correlated proteomics analysis. doi:10.1002/pmic.201400258 PubMed
- [44] Imad A-J Thanoon et al.. Sultan Qaboos Univ Med J. 2012. Oxidative Stress and C-Reactive Protein in Patients with Cerebrovascular Accident (Ischaemic Stroke): The role of Ginkgo biloba extract. doi:10.12816/0003113 PubMed
- [45] Klaus P Ebmeier. Practitioner. 2010. Normal cognitive decline or dementia? PubMed
- [46] Oleksandr Napryeyenko et al.. J Neurol Sci. 2009. Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. doi:10.1016/j.jns.2009.02.353 PubMed
- [47] . Prescrire Int. 2007. Ginkgo and Alzheimer's disease: little or no different from placebo. PubMed
- [48] Zahoor Ahmad Shah et al.. Eur Neuropsychopharmacol. 2003. Ginkgo biloba normalises stress-elevated alterations in brain catecholamines, serotonin and plasma corticosterone levels. doi:10.1016/s0924-977x(03)00005-1 PubMed
- [49] Laura L Boles Ponto et al.. Ann Clin Psychiatry. 2003. Ginkgo biloba extract: review of CNS effects. doi:10.1023/a:1024688326023 PubMed
- [50] Victor S Sierpina et al.. Am Fam Physician. 2003. Ginkgo biloba. PubMed
- [51] Lauren T Bonner et al.. Med Clin North Am. 2002. Pharmacologic treatments of dementia. doi:10.1016/s0025-7125(02)00007-x PubMed
- [52] D J McKenna et al.. Altern Ther Health Med. 2001. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. PubMed
- [53] B J Diamond et al.. Arch Phys Med Rehabil. 2000. Ginkgo biloba extract: mechanisms and clinical indications. doi:10.1016/s0003-9993(00)90052-2 PubMed
- [54] S Logani et al.. Life Sci. 2000. Actions of Ginkgo Biloba related to potential utility for the treatment of conditions involving cerebral hypoxia. doi:10.1016/s0024-3205(00)00741-4 PubMed
- [55] V Evans. J Neurosci Nurs. 2000. Herbs and the brain: friend or foe? The effects of ginkgo and garlic on warfarin use. doi:10.1097/01376517-200008000-00007 PubMed
- [56] W J Riedel et al.. Curr Opin Clin Nutr Metab Care. 1998. Nutrients, age and cognitive function. doi:10.1097/00075197-199811000-00017 PubMed
Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.